Harm reduction

Enhancing hepatitis B and C prevention among people who use drugs: Evaluating an educational intervention at a drop-in center in southwest Iran based on Protection Motivation Theory More

Integrating facilitated telemedicine into opioid treatment programs led to sustained virological response, improved patient satisfaction, and long-term health gains 5 years post-cure. More

Treatment Action Group releases a trials tracker providing a compilation of ongoing and recently completed clinical trials on long-acting therapies for HCV, opioid use and overdose prevention therapy, and malaria in the R&D pipeline. More